AHR and breast carcinoma: Altogether, our data reveal a new/original signature based on a combination of high AhR mRNA expression levels and high GPR30 mRNA expression levels that represents a novel marker for poor prognosis in breast cancer, especially in ER-negative or triple-negative subclasses.